4.7 Letter

COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020

Journal

EMERGING INFECTIOUS DISEASES
Volume 27, Issue 2, Pages 641-643

Publisher

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2702.204041

Keywords

-

Funding

  1. Novavax
  2. Medimmune corporations
  3. Starship Foundation
  4. University of Auckland
  5. CureKids
  6. Health Research Council of New Zealand
  7. Auckland Medical Research Foundation
  8. National Health and Medical and Health Research Council of Australia

Ask authors/readers for more resources

In March 2020, New Zealand implemented a national elimination strategy for coronavirus disease, leading to a significant decrease in hospitalizations for lower respiratory tract infections among infants <2 years of age and cases of respiratory syncytial or influenza virus infection. These findings suggest additional benefits of coronavirus disease control strategies.
In March 2020, a national elimination strategy for coronavirus disease was introduced in New Zealand. Since then, hospitalizations for lower respiratory tract infection among infants <2 years of age and cases of respiratory syncytial or influenza virus infection have dramatically decreased. These findings indicate additional benefits of coronavirus disease control strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available